Current Pharmaceutical Design

302.9k citations
9.9k papers · · active since 1950

Impact in

Papers in

Current Pharmaceutical Design

8.6k papers receiving 275.2k citations

Peers

Current Pharmaceutical Design
Comparison fields: 5 of 236
  • Biological Psychiatry 5.3k
  • Molecular Biology 105.6k
  • Pharmacology 22.6k
  • Molecular Medicine 6.3k
  • Cancer Research 17.0k
Replace Pharmacological Research with:
Pharmacological Research Italy
Current Medicinal Chemistry Italy
Frontiers in Pharmacology China
Biomedicine & Pharmacotherapy China
International Immunopharmacology China
Advances in experimental medicine and biology United States
Pharmacology & Therapeutics United States
Biological and Pharmaceutical Bulletin Japan
Food and Chemical Toxicology United States
Oxidative Medicine and Cellular Longevity China
Current Pharmaceutical Design relative to Pharmacological Research Italy Pharmacological Research's profile →
Citations per field
00.5×1.7×
Pharmacological Research · 1×
Citations per year

Countries where authors publish in Current Pharmaceutical Design

Since Specialization
Citations

This map shows the geographic impact of research published in Current Pharmaceutical Design. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Pharmaceutical Design with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Pharmaceutical Design more than expected).

Fields of papers published in Current Pharmaceutical Design

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Current Pharmaceutical Design. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Pharmaceutical Design.

About Current Pharmaceutical Design

The 9.9k papers published in Current Pharmaceutical Design in the last decades have received a total of 302.9k indexed citations . Papers published in Current Pharmaceutical Design usually cover Pharmaceutical Science (352 papers), Biological Psychiatry (128 papers), Pharmacology (708 papers), Molecular Biology (2.9k papers) and Cancer Research (533 papers) specifically the topics of Computational Drug Discovery Methods (363 papers), Nanoparticle-Based Drug Delivery (281 papers), RNA Interference and Gene Delivery (238 papers), Monoclonal and Polyclonal Antibodies Research (210 papers), Advanced Drug Delivery Systems (173 papers), Receptor Mechanisms and Signaling (152 papers), Neuroscience and Neuropharmacology Research (146 papers) and Lipoproteins and Cardiovascular Health (144 papers). The most active scholars publishing in Current Pharmaceutical Design are Claudiu T. Supuran, Sho‐ichi Yamagishi, Amirhossein Sahebkar, K. Hüsnü Can Başer, Michael J. Rogers, William A. Banks, James E. Klaunig, David J. Begley, Paul E. Marik and Anne Pihlanto.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact